Clinical trial
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
NCT04653194 is registered in ClinicalTrials.gov with Chelsea and Westminster NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
- Lead sponsor
- Chelsea and Westminster NHS Foundation Trust
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2020
- Completion date
- July 31, 2023
- Enrollment
- 36 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus